Siegfried Holding AG (SWX:SFZN)

Market Cap	3.47B -20.2%
Revenue (ttm)	1.33B +2.6%
Net Income	168.66M +5.4%
EPS	3.84 +4.1%
Shares Out	43.81M
PE Ratio	20.63
Forward PE	19.28
Dividend	0.40 (0.51%)
Ex-Dividend Date	Apr 22, 2025

Volume	88,285
Average Volume	137,439
Open	78.40
Previous Close	79.20
Day's Range	77.90 - 80.20
52-Week Range	53.70 - 101.60
Beta	0.74
RSI	38.35
Earnings Date	Feb 20, 2026

About Siegfried Holding AG

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1873
• Employees: 3,891
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: SFZN

Financial Performance

In 2025, Siegfried Holding AG's revenue was 1.33 billion, an increase of 2.57% compared to the previous year's 1.29 billion. Earnings were 168.66 million, an increase of 5.37%.